Extent of surgical resection and adjuvant temozolomide improves survival in pediatric GBM: a single center experience
Authors:
- 19 April 2017
- journal article
- research article
- Published by Springer Nature in Child's Nervous System
- Vol. 33 (6) , 951-956
Abstract
Pediatric glioblastoma (pGBM) is an uncommon entity. The importance of concurrent and adjuvant temozolomide is not known in this subset of patients.Keywords
This publication has 24 references indexed in Scilit:
- Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 studyNeuro-Oncology, 2016
- Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-OncologyJournal of Neuro-Oncology, 2014
- Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcomeChild's Nervous System, 2012
- Glioblastoma in Children: A Single-Institution ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupNeuro-Oncology, 2011
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Expression of p53, EGFR, pRb and bcl-2 Proteins in Pediatric Glioblastoma Multiforme: A Study of 54 PatientsPediatric Neurosurgery, 2005
- Temozolomide in paediatric high-grade glioma: a key for combination therapy?British Journal of Cancer, 2004
- Temozolomide in Malignant Gliomas of Childhood: A United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup StudyJournal of Clinical Oncology, 2002
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990